Comparative study of total antibody titer against SARS-CoV-2 spike protein between male and female COVID- 19 patients of different age groups in UAE

Abstract

Abstract Introduction/Objective Currently, there is increasing evidence that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes men to experience more serious symptoms and have a higher mortality rate than women, but the associations between gender and age groups are still elusive. This study aimed to examine the associations with age, gender, and clinical parameters of total antibody responses against the spike protein of SARS- CoV-2 after infection in UAE population. Methods/Case Report In this study, spike protein antibody titer estimation for COVID-19 positive individuals (n = 1070) was determined. A cross-sectional study design was planned in which patients were divided into nine groups (based on their age) and further subdivided into two groups based on their genders (9 x 2). Serum was collected from the patients after 17 days of diagnosis as COVID-19 positive by RT-PCR method. Concentrations of SARS-CoV-2 Total antibody (COV2T) were measured by chemiluminescent immunoassay using ADVIA Centaur® XPT systems. We used a mixed effects model to investigate the potential associations of antibodies by bootstrapping t-tests of the putative effects of gender and age of the individuals. Results (if a Case Study enter NA) There were significant differences (P< 0.05) between males and females for SARS-CoV-2 total antibody reactivity. Total 645 (50.4%) male were found reactive compared to 425 (31.2%) female. Noteworthy, the group having middle-aged (41-50 years) participants depicted a higher antibody titer in both males and female against SARS-CoV-2. A significant decrease in titers also observed with different age groups. Highest number of reactive individuals were observed in 41-50 years age group (31%), followed by 31-40 years (27.34%), 51- 60 years (15.21%) and 21-30 years (13.04%). Same pattern of number of reactive individuals was found in male and female of different age group. Moreover, despite there being a weak significant positive association between age and total antibody titre in male patients, while there was no significant correlation between gender and age for the antibody response. Conclusion In a nutshell, total antibody (COV2T) reactivity was found significantly associated with male group and that was highest in 41-50 years age group, irrespective of the gender. These findings are crucial to treat and care for male and female patients infected with COVID-19 at hospitals.